Mix, T. et al. (2005) Rationale - Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease. American Heart Journal, 149, pp. 408-413. (doi: 10.7016/j.ahj.2004.09.047)
Full text not currently available from Enlighten.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | McMurray, Professor John |
| Authors: | Mix, T., Brenner, R., Cooper, M., de Zeeuw, D., Ivanovich, P., Levey, A., McGill, J., McMurray, J., Parfrey, P., Parving, H., Pereira, B., Remuzzi, G., Singh, A., Solomon, S., Stehman-Breen, C., Toto, R., and Pfeffer, M. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health College of Medical Veterinary and Life Sciences |
| Journal Name: | American Heart Journal |
University Staff: Request a correction | Enlighten Editors: Update this record
Altmetric
Altmetric